118 related articles for article (PubMed ID: 6788802)
1. Characterization of monoclonal antibodies against human apolipoprotein E.
Milne RW; Douste-Blazy P; Marcel YL; Retegui L
J Clin Invest; 1981 Jul; 68(1):111-7. PubMed ID: 6788802
[TBL] [Abstract][Full Text] [Related]
2. Characterization of high density lipoprotein binding to human adipocyte plasma membranes.
Fong BS; Rodrigues PO; Salter AM; Yip BP; Despres JP; Angel A; Gregg RE
J Clin Invest; 1985 Jun; 75(6):1804-12. PubMed ID: 2989332
[TBL] [Abstract][Full Text] [Related]
3. Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins.
Krul ES; Tikkanen MJ; Cole TG; Davie JM; Schonfeld G
J Clin Invest; 1985 Feb; 75(2):361-9. PubMed ID: 3973009
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a monoclonal antibody that binds to apolipoprotein E and to lipoprotein of human plasma containing apo E. Applications to ELISA quantification of plasma apo E.
Leroy A; Vu-dac N; Koffigan M; Clavey V; Fruchart JC
J Immunoassay; 1988; 9(3-4):309-34. PubMed ID: 3235687
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies to human apolipoproteins: application to the study of high density lipoprotein subpopulations.
Bustos P; Ulloa N; Calvo C; Muller D; Durán D; Martínez J; Salazar L; Quiroga A
Clin Chim Acta; 2000 Sep; 299(1-2):151-67. PubMed ID: 10900301
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunoassay of apolipoprotein A-I of rat serum.
Fainaru M; Havel RJ; Felker TE
Biochim Biophys Acta; 1976 Sep; 446(1):56-68. PubMed ID: 184835
[TBL] [Abstract][Full Text] [Related]
7. Immunochemical heterogeneity of human plasma high density lipoproteins. Identification with apolipoprotein A-I- and A-II-specific monoclonal antibodies.
Curtiss LK; Edgington TS
J Biol Chem; 1985 Mar; 260(5):2982-93. PubMed ID: 2579072
[TBL] [Abstract][Full Text] [Related]
8. Enzyme-linked immunoabsorbant assay of apolipoprotein AII in plasma, with use of a monoclonal antibody.
Stein EA; DiPersio L; Pesce AJ; Kashyap M; Kao JT; Srivastava L; McNerney C
Clin Chem; 1986 Jun; 32(6):967-71. PubMed ID: 3085983
[TBL] [Abstract][Full Text] [Related]
9. [Effects of apolipoproteins AI, CI, CII, CIII and E on the binding of 125I-labeled apoE-deficient HDL3 to rat liver plasma membranes].
Zhang L; Liu B
Hua Xi Yi Ke Da Xue Xue Bao; 1991 Jun; 22(2):120-3. PubMed ID: 1664812
[TBL] [Abstract][Full Text] [Related]
10. Detection of unique antigenic determinants on human plasma low density lipoprotein and on delipidated apolipoprotein B.
Watt TS; Watt RM
Proc Natl Acad Sci U S A; 1983 Jan; 80(1):124-8. PubMed ID: 6185956
[TBL] [Abstract][Full Text] [Related]
11. Immunochemical characterization of apolipoprotein A-I from normal human plasma. In vitro modification of apo A-I antigens.
Milthorp P; Weech PK; Milne RW; Marcel YL
Arteriosclerosis; 1986; 6(3):285-96. PubMed ID: 3085646
[TBL] [Abstract][Full Text] [Related]
12. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
Delgado Alves J; Kumar S; Isenberg DA
Rheumatology (Oxford); 2003 Jul; 42(7):893-9. PubMed ID: 12730551
[TBL] [Abstract][Full Text] [Related]
13. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
Rubinstein A; Gibson JC; Paterniti JR; Kakis G; Little A; Ginsberg HN; Brown WV
J Clin Invest; 1985 Feb; 75(2):710-21. PubMed ID: 3973025
[TBL] [Abstract][Full Text] [Related]
14. Characterization of monoclonal anti-rabbit apolipoprotein E antibodies and chemical composition of lipoproteins separated by anti-apolipoprotein E immuno-affinity chromatography.
Yoon TH; Mori N; Kitamura K; Ishibashi S; Shimano H; Mokuno H; Gotoda T; Takaku F; Yamada N
J Biochem; 1991 Feb; 109(2):204-10. PubMed ID: 1864834
[TBL] [Abstract][Full Text] [Related]
15. Distribution of high density lipoprotein particles with different apoprotein composition: particles with A-I and A-II and particles with A-I but no A-II.
Cheung MC; Albers JJ
J Lipid Res; 1982 Jul; 23(5):747-53. PubMed ID: 6811682
[TBL] [Abstract][Full Text] [Related]
16. Characterization of five mouse monoclonal antibodies to apolipoprotein[a] from human Lp[a]: evidence for weak plasminogen reactivity.
Guo HC; Armstrong VW; Luc G; Billardon C; Goulinet S; Nustede R; Seidel D; Chapman MJ
J Lipid Res; 1989 Jan; 30(1):23-37. PubMed ID: 2521888
[TBL] [Abstract][Full Text] [Related]
17. Characterization of monoclonal antibodies against apolipoproteins A-I and A-II. Epitope expression in LpA-I and LpA-I:A-II particles.
Ulloa N; Bustos P; Castro G; Fruchart J; Vera M; Fruchart JC; Calvo C
Hybridoma; 1999 Dec; 18(6):513-20. PubMed ID: 10626680
[TBL] [Abstract][Full Text] [Related]
18. Hepatic secretion of lipoproteins in the rat and the effect of experimental nephrosis.
Marsh JB; Sparks CE
J Clin Invest; 1979 Nov; 64(5):1229-37. PubMed ID: 227928
[TBL] [Abstract][Full Text] [Related]
19. Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia.
Ehnholm C; Mahley RW; Chappell DA; Weisgraber KH; Ludwig E; Witztum JL
Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5566-70. PubMed ID: 6591204
[TBL] [Abstract][Full Text] [Related]
20. Recent progress in the development of radioimmunoassays for human serum lipoproteins.
Karlin JB; Juhn DJ; Goldberg R; Rubenstein AH
Ann Clin Lab Sci; 1978; 8(2):142-54. PubMed ID: 205163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
